| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.677 | 0.001 | 0.737 | 5 Hydroxytryptamine 4 agonist | 0.342 0.001 DBMET01633 0.374 0.001 DBMET01634 0.737 0.001 DBMET00355 | DBMET00355 | |
| 0.651 | 0.001 | 0.651 | 5 Hydroxytryptamine 4 antagonist | 0.399 0.002 DBMET01633 0.443 0.002 DBMET01634 0.532 0.001 DBMET00355 | ||
| 0.637 | 0.005 | 0.637 | 5 Hydroxytryptamine antagonist | 0.307 0.018 DBMET01633 0.389 0.012 DBMET01634 0.396 0.012 DBMET00355 | ||
| 0.451 | 0.005 | 0.633 | 5 Hydroxytryptamine agonist | 0.364 0.006 DBMET01633 0.342 0.007 DBMET01634 0.633 0.004 DBMET00355 | DBMET00355 | |
| 0.447 | 0.02 | 0.447 | Potassium channel (Voltage-sensitive) blocker | 0.29 0.053 DBMET01633 0.305 0.048 DBMET01634 0.387 0.029 DBMET00355 | ||
| 0.416 | 0.004 | 0.416 | 5 Hydroxytryptamine 1E antagonist | 0.184 0.15 DBMET01632 0.334 0.014 DBMET01633 0.366 0.007 DBMET01634 0.366 0.007 DBMET00355 | ||
| 0.432 | 0.023 | 0.432 | HERG channel blocker | 0.278 0.056 DBMET01633 0.294 0.05 DBMET01634 0.372 0.033 DBMET00355 | ||
| 0.39 | 0.041 | 0.397 | Nootropic | 0.284 0.082 DBMET01633 0.32 0.065 DBMET01634 0.397 0.039 DBMET00355 | DBMET00355 | |
| 0.337 | 0.036 | 0.337 | Potassium channel blocker | 0.199 0.093 DBMET01633 0.21 0.086 DBMET01634 0.244 0.069 DBMET00355 | ||
| 0.314 | 0.032 | 0.314 | Ca(v)3.3 blocker | 0.314 0.031 DBMET01632 0.259 0.087 DBMET01633 0.282 0.059 DBMET01634 | ||
| 0.284 | 0.011 | 0.295 | Dopamine D2 antagonist | 0.188 0.018 DBMET01633 0.295 0.01 DBMET01634 | DBMET01634 | |
| 0.278 | 0.013 | 0.29 | Dopamine antagonist | 0.201 0.019 DBMET01633 0.29 0.012 DBMET01634 | DBMET01634 | |
| 0.277 | 0.016 | 0.277 | 5 Hydroxytryptamine 2B antagonist | 0.141 0.045 DBMET01633 0.181 0.03 DBMET01634 0.131 0.051 DBMET00355 | ||
| 0.266 | 0.019 | 0.266 | 5 Hydroxytryptamine 2 antagonist | 0.13 0.053 DBMET01633 0.157 0.042 DBMET01634 | ||
| 0.224 | 0.005 | 0.528 | 5 Hydroxytryptamine 3 antagonist | 0.063 0.033 DBMET01633 0.07 0.029 DBMET01634 0.528 0.003 DBMET00355 | DBMET00355 | |
| 0.292 | 0.073 | 0.319 | Spasmolytic | 0.208 0.113 DBMET01633 0.319 0.063 DBMET01634 0.271 0.082 DBMET00355 | DBMET01634 | |
| 0.201 | 0.004 | 0.318 | 5 Hydroxytryptamine 3A antagonist | 0.087 0.025 DBMET01633 0.094 0.02 DBMET01634 0.318 0.003 DBMET00355 | DBMET00355 | |
| 0.202 | 0.03 | 0.213 | MAP kinase kinase 5 inhibitor | 0.151 0.147 DBMET01632 0.189 0.047 DBMET01633 0.184 0.055 DBMET01634 0.213 0.021 DBMET00355 | DBMET00355 | |
| 0.306 | 0.137 | 0.319 | Analgesic | 0.301 0.141 DBMET01633 0.286 0.153 DBMET01634 0.319 0.128 DBMET00355 | DBMET00355 | |
| 0.193 | 0.025 | 0.215 | Alpha 2b adrenoreceptor antagonist | 0.111 0.065 DBMET01633 0.183 0.028 DBMET01634 0.215 0.021 DBMET00355 | DBMET00355 | |
| 0.174 | 0.013 | 0.174 | Dopamine D3 antagonist | 0.076 0.035 DBMET01633 0.116 0.021 DBMET01634 | ||
| 0.164 | 0.007 | 0.22 | DNA gyrase inhibitor | 0.145 0.009 DBMET01633 0.147 0.009 DBMET01634 0.22 0.005 DBMET00355 | DBMET00355 | |
| 0.176 | 0.023 | 0.176 | 5 Hydroxytryptamine 2A antagonist | 0.087 0.055 DBMET01633 0.098 0.048 DBMET01634 | ||
| 0.238 | 0.088 | 0.238 | Interleukin agonist | 0.225 0.099 DBMET01632 0.236 0.089 DBMET01634 0.226 0.097 DBMET00355 | ||
| 0.219 | 0.07 | 0.219 | Anticonvulsant | 0.145 0.136 DBMET00355 | ||
| 0.29 | 0.145 | 0.367 | MAP kinase kinase 6 inhibitor | 0.243 0.2 DBMET01633 0.247 0.195 DBMET01634 0.367 0.08 DBMET00355 | DBMET00355 | |
| 0.146 | 0.013 | 0.146 | Glutamate (mGluR7) agonist | 0.118 0.033 DBMET01632 0.118 0.032 DBMET01633 0.123 0.028 DBMET01634 0.131 0.021 DBMET00355 | ||
| 0.298 | 0.167 | 0.394 | 5 Hydroxytryptamine release inhibitor | 0.394 0.082 DBMET01632 0.315 0.149 DBMET00355 | DBMET01632 | |
| 0.17 | 0.041 | 0.17 | Anesthetic local | 0.106 0.077 DBMET01632 0.114 0.071 DBMET01633 0.129 0.061 DBMET01634 | ||
| 0.224 | 0.1 | 0.224 | Cardiotonic | 0.177 0.143 DBMET01633 0.207 0.112 DBMET01634 0.171 0.15 DBMET00355 | ||
| 0.156 | 0.036 | 0.177 | Alpha adrenoreceptor antagonist | 0.095 0.06 DBMET01633 0.177 0.031 DBMET01634 | DBMET01634 | |
| 0.203 | 0.086 | 0.204 | ErbB-1 antagonist | 0.204 0.085 DBMET01632 0.176 0.122 DBMET01633 0.201 0.088 DBMET01634 | DBMET01632 | |
| 0.146 | 0.034 | 0.146 | Alpha 2c adrenoreceptor antagonist | 0.133 0.041 DBMET01634 0.119 0.05 DBMET00355 | ||
| 0.123 | 0.011 | 0.193 | Protein kinase C eta inhibitor | 0.114 0.014 DBMET01633 0.119 0.013 DBMET01634 0.193 0.005 DBMET00355 | DBMET00355 | |
| 0.114 | 0.004 | 0.223 | 5 Hydroxytryptamine 3B antagonist | 0.041 0.02 DBMET01633 0.047 0.016 DBMET01634 0.223 0.003 DBMET00355 | DBMET00355 | |
| 0.116 | 0.01 | 0.172 | Protein kinase C epsilon inhibitor | 0.091 0.015 DBMET01633 0.098 0.013 DBMET01634 0.172 0.004 DBMET00355 | DBMET00355 | |
| 0.207 | 0.103 | 0.255 | MAP kinase kinase 3 inhibitor | 0.194 0.139 DBMET01633 0.191 0.151 DBMET01634 0.255 0.027 DBMET00355 | DBMET00355 | |
| 0.188 | 0.086 | 0.198 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.156 0.124 DBMET01633 0.187 0.086 DBMET01634 0.198 0.075 DBMET00355 | DBMET00355 | |
| 0.114 | 0.021 | 0.184 | Dopamine D1 antagonist | 0.141 0.016 DBMET01633 0.184 0.012 DBMET01634 | DBMET01634 | |
| 0.152 | 0.075 | 0.152 | Cholinergic | 0.118 0.111 DBMET01633 0.133 0.092 DBMET01634 0.142 0.083 DBMET00355 | ||
| 0.089 | 0.017 | 0.089 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.138 | 0.069 | 0.138 | Calcium channel blocker | 0.108 0.103 DBMET01632 | ||
| 0.109 | 0.04 | 0.113 | Alpha 1 adrenoreceptor antagonist | 0.113 0.039 DBMET01634 | DBMET01634 | |
| 0.103 | 0.036 | 0.107 | ATPase (Vacuolar H+) inhibitor | 0.105 0.034 DBMET01633 0.107 0.031 DBMET01634 0.107 0.031 DBMET00355 | DBMET00355 | |
| 0.1 | 0.036 | 0.16 | Alpha 2a adrenoreceptor antagonist | 0.127 0.027 DBMET01634 0.16 0.02 DBMET00355 | DBMET00355 | |
| 0.105 | 0.048 | 0.183 | Protein kinase C delta inhibitor | 0.093 0.059 DBMET01633 0.097 0.055 DBMET01634 0.183 0.011 DBMET00355 | DBMET00355 | |
| 0.111 | 0.054 | 0.111 | Chemokine receptor antagonist | 0.085 0.08 DBMET01634 0.098 0.064 DBMET00355 | ||
| 0.125 | 0.069 | 0.158 | Nav1.3 sodium channel blocker | 0.158 0.043 DBMET01632 | DBMET01632 | |
| 0.078 | 0.024 | 0.078 | Alpha 1 adrenoreceptor agonist | 0.056 0.041 DBMET01633 0.077 0.024 DBMET01634 | ||
| 0.091 | 0.04 | 0.091 | Alpha 1a adrenoreceptor antagonist | 0.086 0.042 DBMET01634 | ||
| 0.095 | 0.048 | 0.095 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.085 | 0.039 | 0.085 | 5 Hydroxytryptamine 1F antagonist | 0.06 0.059 DBMET01634 0.069 0.051 DBMET00355 | ||
| 0.094 | 0.049 | 0.205 | Protein kinase A inhibitor | 0.073 0.068 DBMET01633 0.087 0.055 DBMET01634 0.205 0.013 DBMET00355 | DBMET00355 | |
| 0.094 | 0.052 | 0.12 | Alpha 2 adrenoreceptor antagonist | 0.076 0.072 DBMET01633 0.102 0.047 DBMET01634 0.12 0.037 DBMET00355 | DBMET00355 | |
| 0.049 | 0.007 | 0.049 | CC chemokine 1 receptor antagonist | 0.047 0.007 DBMET01633 0.042 0.008 DBMET01634 | ||
| 0.137 | 0.096 | 0.137 | Sigma receptor agonist | 0.121 0.114 DBMET01633 0.12 0.115 DBMET01634 | ||
| 0.086 | 0.046 | 0.086 | CC chemokine receptor antagonist | |||
| 0.074 | 0.035 | 0.074 | Dopamine D4 antagonist | 0.051 0.048 DBMET01634 | ||
| 0.106 | 0.069 | 0.111 | EphA2 antagonist | 0.097 0.079 DBMET01634 0.111 0.063 DBMET00355 | DBMET00355 | |
| 0.057 | 0.021 | 0.057 | CC chemokine 3 receptor antagonist | |||
| 0.079 | 0.044 | 0.083 | Nav1.8 sodium channel blocker | 0.083 0.039 DBMET01633 0.083 0.039 DBMET01634 0.081 0.041 DBMET00355 | DBMET01634 | |
| 0.098 | 0.063 | 0.098 | Insulin receptor antagonist | |||
| 0.139 | 0.107 | 0.146 | Interleukin 6 antagonist | 0.146 0.095 DBMET01634 0.143 0.099 DBMET00355 | DBMET01634 | |
| 0.085 | 0.054 | 0.085 | ErbB-3 antagonist | |||
| 0.148 | 0.12 | 0.152 | P-glycoprotein inhibitor | 0.152 0.114 DBMET01634 | DBMET01634 | |
| 0.04 | 0.011 | 0.055 | Protein kinase C beta II inhibitor | 0.039 0.012 DBMET01633 0.04 0.011 DBMET01634 0.055 0.005 DBMET00355 | DBMET00355 | |
| 0.038 | 0.011 | 0.046 | Protein kinase C beta I inhibitor | 0.037 0.013 DBMET01633 0.037 0.013 DBMET01634 0.046 0.005 DBMET00355 | DBMET00355 | |
| 0.07 | 0.044 | 0.152 | Protein kinase C alpha inhibitor | 0.064 0.053 DBMET01634 0.152 0.01 DBMET00355 | DBMET00355 | |
| 0.113 | 0.088 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.085 DBMET00355 | DBMET00355 | |
| 0.059 | 0.034 | 0.149 | Acetylcholine muscarinic agonist | 0.149 0.01 DBMET00355 | DBMET00355 | |
| 0.052 | 0.03 | 0.052 | Sodium/calcium exchanger inhibitor | 0.051 0.032 DBMET01632 | ||
| 0.139 | 0.121 | 0.186 | ATPase inhibitor | 0.186 0.051 DBMET01632 0.162 0.083 DBMET01634 | DBMET01632 | |
| 0.071 | 0.053 | 0.071 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.069 | 0.053 | 0.069 | Alpha 1b adrenoreceptor antagonist | 0.065 0.057 DBMET01634 | ||
| 0.036 | 0.023 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.023 DBMET01632 | DBMET01632 | |
| 0.085 | 0.077 | 0.085 | Butyrylcholinesterase inhibitor | |||
| 0.046 | 0.039 | 0.046 | CC chemokine receptor 2B antagonist | |||
| 0.029 | 0.023 | 0.037 | DNA topoisomerase IV inhibitor | 0.037 0.01 DBMET00355 | DBMET00355 | |
| 0.104 | 0.098 | 0.104 | Acetylcholinesterase inhibitor | |||
| 0.078 | 0.073 | 0.088 | Antiadrenergic | 0.088 0.064 DBMET01634 | DBMET01634 | |
| 0.057 | 0.052 | 0.057 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.083 | 0.08 | 0.143 | Glutamate release inhibitor | 0.143 0.011 DBMET01632 | DBMET01632 | |
| 0.051 | 0.048 | 0.051 | Alpha 1d adrenoreceptor antagonist | |||
| 0.033 | 0.03 | 0.041 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET01633 0.033 0.031 DBMET01634 0.041 0.02 DBMET00355 | DBMET00355 | |
| 0.059 | 0.056 | 0.087 | Alpha adrenoreceptor agonist | 0.069 0.047 DBMET01634 0.087 0.034 DBMET00355 | DBMET00355 | |
| 0.058 | 0.055 | 0.058 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.129 | 0.127 | 0.144 | Amyloid beta precursor protein antagonist | 0.144 0.108 DBMET01632 0.134 0.12 DBMET01634 | DBMET01632 | |
| 0.075 | 0.073 | 0.19 | Acetylcholine agonist | 0.19 0.016 DBMET00355 | DBMET00355 | |
| 0.074 | 0.074 | 0.085 | Adrenaline antagonist | 0.085 0.064 DBMET01634 | DBMET01634 | |
| 0.067 | 0.067 | 0.099 | Focal adhesion kinase 1 inhibitor | 0.099 0.031 DBMET00355 | DBMET00355 | |
| 0.089 | 0.09 | 0.1 | Toll-Like receptor 4 antagonist | 0.1 0.07 DBMET01632 0.094 0.08 DBMET01634 | DBMET01632 | |
| 0.103 | 0.106 | 0.162 | Nav1.2 sodium channel blocker | 0.162 0.05 DBMET01632 | DBMET01632 | |
| 0.059 | 0.063 | 0.084 | Potassium channel large-conductance Ca-activated activator | 0.062 0.057 DBMET01633 0.084 0.033 DBMET00355 | DBMET00355 | |
| 0.069 | 0.074 | 0.11 | Adrenaline agonist | 0.11 0.031 DBMET01633 0.097 0.039 DBMET01634 0.071 0.07 DBMET00355 | DBMET01633 | |
| 0.086 | 0.093 | 0.135 | AMP-activated protein kinase stimulant | 0.135 0.038 DBMET01633 0.123 0.046 DBMET01634 | DBMET01633 | |
| 0.112 | 0.125 | 0.141 | Farnesoid X receptor antagonist | 0.136 0.072 DBMET01632 0.141 0.063 DBMET01633 0.124 0.094 DBMET01634 | DBMET01633 | |
| 0.086 | 0.1 | 0.123 | Topoisomerase II inhibitor | 0.113 0.073 DBMET01634 0.123 0.065 DBMET00355 | DBMET00355 | |
| 0.043 | 0.065 | 0.068 | 5 Hydroxytryptamine 7 antagonist | 0.068 0.038 DBMET00355 | DBMET00355 | |
| 0.158 | 0.187 | 0.278 | Nitric-oxide synthase stimulant | 0.278 0.018 DBMET01632 0.197 0.094 DBMET00355 | DBMET01632 | |
| 0.076 | 0.109 | 0.09 | Nav1.1 sodium channel blocker | 0.09 0.081 DBMET01632 | DBMET01632 | |
| 0.134 | 0.168 | 0.24 | Antiamyloidogenic | 0.24 0.076 DBMET01634 | DBMET01634 | |
| 0.117 | 0.152 | 0.182 | Tumour necrosis factor antagonist | 0.13 0.128 DBMET01632 0.182 0.066 DBMET00355 | DBMET00355 | |
| 0.093 | 0.133 | 0.125 | Interleukin 4 antagonist | 0.125 0.079 DBMET01634 | DBMET01634 | |
| 0.052 | 0.094 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.035 DBMET01633 0.059 0.053 DBMET01634 | DBMET01633 | |
| 0.03 | 0.071 | 0.045 | Dopamine transporter inhibitor | 0.045 0.037 DBMET00355 | DBMET00355 | |
| 0.093 | 0.136 | 0.121 | Protein kinase C nu inhibitor | 0.121 0.091 DBMET00355 | DBMET00355 | |
| 0.041 | 0.085 | 0.062 | Cyclin D1 inhibitor | 0.062 0.04 DBMET01632 | DBMET01632 | |
| 0.057 | 0.102 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DBMET01632 | DBMET01632 | |
| 0.084 | 0.132 | 0.115 | Acetylcholine release stimulant | 0.115 0.057 DBMET00355 | DBMET00355 | |
| 0.046 | 0.098 | 0.079 | Caspase 9 inhibitor | 0.079 0.024 DBMET01632 | DBMET01632 | |
| 0.174 | 0.225 | 0.213 | Immunosuppressant | 0.213 0.183 DBMET01632 | DBMET01632 | |
| 0.109 | 0.161 | 0.13 | Death-associated protein kinase 1 inhibitor | 0.13 0.08 DBMET00355 | DBMET00355 | |
| 0.075 | 0.13 | 0.166 | Protein kinase C gamma inhibitor | 0.166 0.023 DBMET00355 | DBMET00355 | |
| 0.125 | 0.182 | 0.196 | Catenin beta inhibitor | 0.196 0.035 DBMET00355 | DBMET00355 | |
| 0.115 | 0.173 | 0.127 | MAP kinase kinase 4 inhibitor | 0.127 0.126 DBMET01632 | DBMET01632 | |
| 0.069 | 0.127 | 0.095 | MAP kinase kinase 1 inhibitor | 0.095 0.063 DBMET01632 | DBMET01632 | |
| 0.019 | 0.081 | 0.094 | Factor Xa inhibitor | 0.094 0.015 DBMET00355 | DBMET00355 | |
| 0.069 | 0.131 | 0.08 | T cell inhibitor | 0.08 0.065 DBMET00355 | DBMET00355 | |
| 0.037 | 0.102 | 0.067 | Adrenaline uptake inhibitor | 0.067 0.037 DBMET00355 | DBMET00355 | |
| 0.036 | 0.1 | 0.123 | Alpha 2 adrenoreceptor agonist | 0.123 0.01 DBMET00355 | DBMET00355 | |
| 0.066 | 0.136 | 0.109 | 5 Hydroxytryptamine 3A agonist | 0.096 0.081 DBMET01632 0.109 0.066 DBMET00355 | DBMET00355 | |
| 0.033 | 0.103 | 0.108 | Acetylcholine M5 receptor agonist | 0.108 0.016 DBMET01632 | DBMET01632 | |
| 0.12 | 0.194 | 0.169 | Death-associated protein kinase 2 inhibitor | 0.169 0.07 DBMET00355 | DBMET00355 | |
| 0.03 | 0.105 | 0.049 | Alpha 1L adrenoreceptor agonist | 0.049 0.018 DBMET00355 | DBMET00355 | |
| 0.081 | 0.157 | 0.1 | Interleukin 8 antagonist | 0.1 0.096 DBMET00355 | DBMET00355 | |
| 0.077 | 0.155 | 0.107 | CDK3/cyclin E inhibitor | 0.107 0.074 DBMET00355 | DBMET00355 | |
| 0.173 | 0.258 | 0.228 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.228 0.1 DBMET00355 | DBMET00355 | |
| 0.061 | 0.147 | 0.087 | Polo-like kinase-1 inhibitor | 0.087 0.067 DBMET00355 | DBMET00355 | |
| 0.074 | 0.161 | 0.117 | Cyclooxygenase 3 inhibitor | 0.117 0.08 DBMET01632 0.103 0.098 DBMET00355 | DBMET01632 | |
| 0.164 | 0.254 | 0.215 | Toll-Like receptor 7 agonist | 0.215 0.183 DBMET01633 | DBMET01633 | |
| 0.006 | 0.097 | 0.024 | Dopamine autoreceptor agonist | 0.024 0.016 DBMET01632 | DBMET01632 | |
| 0.061 | 0.157 | 0.163 | Protein kinase C zeta inhibitor | 0.092 0.061 DBMET01633 0.163 0.017 DBMET00355 | DBMET00355 | |
| 0.16 | 0.26 | 0.211 | Toll-Like receptor agonist | 0.211 0.189 DBMET01633 | DBMET01633 | |
| 0.05 | 0.16 | 0.146 | Protein kinase C mu inhibitor | 0.146 0.028 DBMET00355 | DBMET00355 | |
| 0.047 | 0.16 | 0.063 | Calcium channel P-type blocker | 0.063 0.045 DBMET01632 | DBMET01632 | |
| 0.079 | 0.194 | 0.149 | Amyloid beta aggregation inhibitor | 0.149 0.108 DBMET01634 | DBMET01634 | |
| 0.163 | 0.279 | 0.322 | Calcium channel activator | 0.322 0.071 DBMET01632 | DBMET01632 | |
| 0.015 | 0.141 | 0.037 | Peroxisome proliferator-activated receptor delta antagonist | 0.037 0.018 DBMET01632 | DBMET01632 | |
| 0.029 | 0.157 | 0.107 | Check point kinase 1 inhibitor | 0.107 0.026 DBMET00355 | DBMET00355 | |
| 0.056 | 0.195 | 0.166 | Nav1.6 sodium channel blocker | 0.166 0.038 DBMET01632 | DBMET01632 | |
| 0.053 | 0.2 | 0.102 | Interleukin 5 antagonist | 0.102 0.039 DBMET01632 | DBMET01632 | |
| 0.054 | 0.202 | 0.105 | Thioredoxin reductase inhibitor | 0.105 0.024 DBMET01632 | DBMET01632 | |
| 0.027 | 0.179 | 0.11 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.11 0.031 DBMET00355 | DBMET00355 | |
| 0.018 | 0.184 | 0.051 | Protein 50S ribosomal subunit inhibitor | 0.051 0.039 DBMET01632 | DBMET01632 | |
| 0.026 | 0.192 | 0.064 | Protein kinase C iota inhibitor | 0.064 0.037 DBMET00355 | DBMET00355 | |
| 0.053 | 0.22 | 0.138 | Interleukin 1b antagonist | 0.138 0.049 DBMET01632 | DBMET01632 | |
| 0.076 | 0.245 | 0.125 | Neuropeptide Y1 antagonist | 0.125 0.111 DBMET01632 | DBMET01632 | |
| 0.051 | 0.221 | 0.121 | Beta amyloid protein antagonist | 0.121 0.066 DBMET01632 | DBMET01632 | |
| 0.03 | 0.2 | 0.124 | Calcium antagonist | 0.124 0.033 DBMET01632 | DBMET01632 | |
| 0.02 | 0.193 | 0.063 | 5 Hydroxytryptamine 2A agonist | 0.063 0.044 DBMET01632 | DBMET01632 | |
| 0.025 | 0.199 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.046 DBMET01632 | DBMET01632 | |
| 0.077 | 0.253 | 0.158 | Sphingosine 1-phosphate receptor 2 antagonist | 0.158 0.031 DBMET01632 | DBMET01632 | |
| 0.057 | 0.238 | 0.124 | Estrogen antagonist | 0.124 0.048 DBMET01633 | DBMET01633 | |
| 0.036 | 0.217 | 0.099 | Pim-3 kinase inhibitor | 0.099 0.047 DBMET00355 | DBMET00355 | |
| 0.023 | 0.205 | 0.076 | Protein kinase C beta inhibitor | 0.076 0.036 DBMET00355 | DBMET00355 | |
| 0.053 | 0.236 | 0.077 | Ca(v)3.1 blocker | 0.077 0.071 DBMET01632 | DBMET01632 | |
| 0.042 | 0.237 | 0.157 | Interleukin 1 beta converting enzyme inhibitor | 0.157 0.015 DBMET01632 | DBMET01632 | |
| 0.037 | 0.235 | 0.083 | Histamine H2 receptor antagonist | 0.083 0.06 DBMET01632 | DBMET01632 | |
| 0.015 | 0.213 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET01632 | DBMET01632 | |
| 0.095 | 0.295 | 0.213 | Hypoglycemic | 0.213 0.101 DBMET01632 | DBMET01632 | |
| 0.011 | 0.219 | 0.07 | Potassium channel Kv1.3 blocker | 0.07 0.015 DBMET01632 | DBMET01632 | |
| 0.054 | 0.263 | 0.122 | Interleukin 1 antagonist | 0.122 0.085 DBMET01632 | DBMET01632 | |
| 0.027 | 0.241 | 0.093 | Check point kinase 2 inhibitor | 0.093 0.072 DBMET00355 | DBMET00355 | |
| 0.012 | 0.226 | 0.049 | Delayed rectifier potassium channel blocker | 0.049 0.012 DBMET01632 | DBMET01632 | |
| 0.016 | 0.23 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.034 DBMET01632 | DBMET01632 | |
| 0.022 | 0.24 | 0.073 | Leucine-rich repeat kinase 2 inhibitor | 0.073 0.065 DBMET00355 | DBMET00355 | |
| 0.074 | 0.296 | 0.237 | Non-steroidal antiinflammatory agent | 0.237 0.048 DBMET01632 | DBMET01632 | |
| 0.046 | 0.272 | 0.393 | ABCA1 expression enhancer | 0.393 0.004 DBMET01632 | DBMET01632 | |
| 0.017 | 0.247 | 0.066 | Neuronal nicotinic receptor antagonist | 0.066 0.049 DBMET00355 | DBMET00355 | |
| 0.016 | 0.251 | 0.074 | Alpha-mannosidase inhibitor | 0.074 0.014 DBMET01632 | DBMET01632 | |
| 0.056 | 0.3 | 0.141 | Heat shock protein 90 antagonist | 0.141 0.084 DBMET00355 | DBMET00355 | |
| 0.042 | 0.293 | 0.123 | Lanosterol 14 alpha demethylase inhibitor | 0.123 0.028 DBMET01632 | DBMET01632 | |
| 0.028 | 0.28 | 0.082 | Myeloperoxidase inhibitor | 0.082 0.063 DBMET01632 | DBMET01632 | |
| 0.018 | 0.273 | 0.036 | Calcium-independent phospholipase A2 inhibitor | 0.036 0.017 DBMET01632 | DBMET01632 | |
| 0.029 | 0.294 | 0.063 | Leukotriene C antagonist | 0.063 0.023 DBMET01632 | DBMET01632 | |
| 0.019 | 0.294 | 0.042 | Leukotriene C4 antagonist | 0.042 0.02 DBMET01632 | DBMET01632 | |
| 0.01 | 0.286 | 0.063 | Mannosidase inhibitor | 0.063 0.015 DBMET01632 | DBMET01632 | |
| 0.03 | 0.307 | 0.098 | Sphingomyelinase inhibitor | 0.098 0.061 DBMET01632 | DBMET01632 | |
| 0.043 | 0.324 | 0.093 | Carbonic anhydrase XV inhibitor | 0.093 0.077 DBMET01632 | DBMET01632 | |
| 0.035 | 0.317 | 0.107 | Estrogen receptor beta antagonist | 0.107 0.051 DBMET01633 | DBMET01633 | |
| 0.015 | 0.302 | 0.029 | Thiazolidinedione | 0.029 0.021 DBMET01632 | DBMET01632 | |
| 0.014 | 0.303 | 0.068 | Nicotinic alpha4beta2 receptor antagonist | 0.068 0.064 DBMET01632 | DBMET01632 | |
| 0.073 | 0.378 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | 0.178 0.025 DBMET01632 | DBMET01632 | |
| 0.032 | 0.338 | 0.123 | Cyclin-dependent kinase 7 inhibitor | 0.123 0.082 DBMET00355 | DBMET00355 | |
| 0.057 | 0.364 | 0.229 | Factor V inhibitor | 0.229 0.003 DBMET01632 | DBMET01632 | |
| 0.009 | 0.318 | 0.105 | MAO B inhibitor | 0.105 0.057 DBMET01632 | DBMET01632 | |
| 0.161 | 0.471 | 0.396 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.396 0.105 DBMET01632 | DBMET01632 | |
| 0.009 | 0.337 | 0.033 | Caspase 6 inhibitor | 0.033 0.015 DBMET01632 | DBMET01632 | |
| 0.018 | 0.348 | 0.071 | Cathepsin B inhibitor | 0.071 0.028 DBMET01632 | DBMET01632 | |
| 0.006 | 0.336 | 0.019 | Caspase 8 inhibitor | 0.019 0.016 DBMET01632 | DBMET01632 | |
| 0.018 | 0.353 | 0.054 | Heparanase inhibitor | 0.054 0.034 DBMET01632 | DBMET01632 | |
| 0.098 | 0.437 | 0.22 | Caspase 3 stimulant | 0.22 0.142 DBMET01632 | DBMET01632 | |
| 0.014 | 0.354 | 0.084 | Lipase inhibitor | 0.084 0.039 DBMET01632 | DBMET01632 | |
| 0.06 | 0.4 | 0.134 | CF transmembrane conductance regulator agonist | 0.134 0.108 DBMET01632 | DBMET01632 | |
| 0.06 | 0.402 | 0.167 | Interferon gamma antagonist | 0.167 0.059 DBMET01632 | DBMET01632 | |
| 0.018 | 0.362 | 0.1 | Potassium channel intermediate-conductance Ca-activated blocker | 0.1 0.009 DBMET01632 | DBMET01632 | |
| 0.021 | 0.368 | 0.043 | Heme oxygenase inhibitor | 0.043 0.029 DBMET01632 | DBMET01632 | |
| 0.021 | 0.376 | 0.228 | Cholesterol synthesis inhibitor | 0.228 0.021 DBMET01632 | DBMET01632 | |
| 0.079 | 0.437 | 0.395 | 5 Hydroxytryptamine release stimulant | 0.395 0.047 DBMET01632 | DBMET01632 | |
| 0.038 | 0.403 | 0.111 | Phosphodiesterase 6D inhibitor | 0.111 0.034 DBMET01632 | DBMET01632 | |
| 0.015 | 0.387 | 0.111 | MAO inhibitor | 0.111 0.08 DBMET01632 | DBMET01632 | |
| 0.045 | 0.43 | 0.123 | Hexokinase inhibitor | 0.123 0.114 DBMET01632 | DBMET01632 | |
| 0.006 | 0.392 | 0.035 | Lysophosphatidic acid 2 receptor antagonist | 0.035 0.016 DBMET01632 | DBMET01632 | |
| 0.016 | 0.408 | 0.06 | Aryl hydrocarbon receptor antagonist | 0.06 0.053 DBMET01632 | DBMET01632 | |
| 0.026 | 0.422 | 0.179 | Anesthetic general | 0.179 0.087 DBMET01632 | DBMET01632 | |
| 0.015 | 0.416 | 0.076 | Phospholipase D inhibitor | 0.076 0.041 DBMET01632 | DBMET01632 | |
| 0.014 | 0.417 | 0.045 | Vanilloid 3 antagonist | 0.045 0.013 DBMET01632 | DBMET01632 | |
| 0.017 | 0.424 | 0.072 | Interferon agonist | 0.072 0.066 DBMET01632 | DBMET01632 | |
| 0.018 | 0.425 | 0.109 | Falcipain 3 inhibitor | 0.109 0.062 DBMET01632 | DBMET01632 | |
| 0.011 | 0.418 | 0.048 | Adenylate cyclase 1 inhibitor | 0.048 0.029 DBMET01632 | DBMET01632 | |
| 0.006 | 0.417 | 0.058 | GABA uptake inhibitor | 0.058 0.011 DBMET01632 | DBMET01632 | |
| 0.069 | 0.481 | 0.262 | Antibacterial | 0.262 0.165 DBMET00355 | DBMET00355 | |
| 0.104 | 0.516 | 0.303 | 5 Hydroxytryptamine uptake stimulant | 0.303 0.043 DBMET01632 0.235 0.097 DBMET00355 | DBMET01632 | |
| 0.053 | 0.475 | 0.216 | Transcription factor NF kappa B inhibitor | 0.216 0.154 DBMET01632 | DBMET01632 | |
| 0.08 | 0.505 | 0.25 | Apoptosis antagonist | 0.25 0.128 DBMET01632 | DBMET01632 | |
| 0.024 | 0.452 | 0.078 | Estrogen receptor alpha antagonist | 0.078 0.051 DBMET01632 | DBMET01632 | |
| 0.002 | 0.432 | 0.054 | Uridine phosphorylase inhibitor | 0.054 0.007 DBMET01632 | DBMET01632 | |
| 0.008 | 0.439 | 0.05 | Dihydroorotase inhibitor | 0.05 0.024 DBMET01632 | DBMET01632 | |
| 0.005 | 0.436 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 DBMET01632 | DBMET01632 | |
| 0.015 | 0.455 | 0.074 | Carbonic anhydrase XIII inhibitor | 0.074 0.055 DBMET01632 | DBMET01632 | |
| 0.002 | 0.442 | 0.016 | 3C-Like protease (MERS coronavirus) inhibitor | 0.016 0.005 DBMET01632 | DBMET01632 | |
| 0.067 | 0.51 | 0.232 | Vasodilator, coronary | 0.232 0.152 DBMET01632 | DBMET01632 | |
| 0.057 | 0.515 | 0.156 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.136 DBMET01632 | DBMET01632 | |
| 0.01 | 0.473 | 0.104 | Leukotriene synthesis inhibitor | 0.104 0.024 DBMET01632 | DBMET01632 | |
| 0.02 | 0.495 | 0.091 | Beta glucuronidase inhibitor | 0.091 0.085 DBMET01632 | DBMET01632 | |
| 0.005 | 0.48 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.028 DBMET01632 | DBMET01632 | |
| 0.046 | 0.523 | 0.18 | Neurotrophic factor enhancer | 0.18 0.098 DBMET01632 | DBMET01632 | |
| 0.01 | 0.489 | 0.075 | Sphingosine 1-phosphate receptor 3 antagonist | 0.075 0.021 DBMET01632 | DBMET01632 | |
| 0.012 | 0.49 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.033 DBMET01632 | DBMET01632 | |
| 0.026 | 0.507 | 0.347 | Amylase inhibitor | 0.347 0.013 DBMET01632 | DBMET01632 | |
| 0.055 | 0.536 | 0.247 | Histamine release inhibitor | 0.247 0.157 DBMET01632 | DBMET01632 | |
| 0.007 | 0.489 | 0.109 | Amidase inhibitor | 0.109 0.02 DBMET01632 | DBMET01632 | |
| 0.016 | 0.501 | 0.104 | Cystathionine beta-synthase inhibitor | 0.104 0.072 DBMET01632 | DBMET01632 | |
| 0.001 | 0.489 | 0.022 | G-protein-coupled receptor 120 agonist | 0.022 0.008 DBMET01632 | DBMET01632 | |
| 0.017 | 0.515 | 0.182 | Caspase 3 inhibitor | 0.182 0.013 DBMET01632 | DBMET01632 | |
| 0.005 | 0.507 | 0.051 | Leukotriene B4 antagonist | 0.051 0.042 DBMET01632 | DBMET01632 | |
| 0.028 | 0.539 | 0.208 | NADPH oxidase inhibitor | 0.208 0.032 DBMET01632 | DBMET01632 | |
| 0.03 | 0.543 | 0.261 | DNA synthesis inhibitor | 0.261 0.06 DBMET01632 | DBMET01632 | |
| 0.082 | 0.596 | 0.424 | Caspase 9 stimulant | 0.424 0.097 DBMET01632 | DBMET01632 | |
| 0.026 | 0.541 | 0.108 | Sphingosine 1-phosphate receptor 4 antagonist | 0.108 0.1 DBMET01632 | DBMET01632 | |
| 0.004 | 0.528 | 0.047 | Glutamate (mGluR group I) agonist | 0.047 0.034 DBMET01632 | DBMET01632 | |
| 0.012 | 0.543 | 0.077 | Pregnane X receptor antagonist | 0.077 0.008 DBMET01632 | DBMET01632 | |
| 0.006 | 0.539 | 0.04 | Estrogen-related receptor gamma antagonist | 0.04 0.005 DBMET01632 | DBMET01632 | |
| 0.027 | 0.567 | 0.123 | Pregnane X receptor agonist | 0.123 0.119 DBMET01632 | DBMET01632 | |
| 0.002 | 0.55 | 0.055 | Free fatty acid receptor 1 antagonist | 0.055 0.007 DBMET01632 | DBMET01632 | |
| 0.003 | 0.552 | 0.048 | Calpain 1 inhibitor | 0.048 0.005 DBMET01632 | DBMET01632 | |
| 0.019 | 0.568 | 0.184 | Arachidonic acid antagonist | 0.184 0.049 DBMET01632 | DBMET01632 | |
| 0.029 | 0.581 | 0.162 | Melanin inhibitor | 0.162 0.067 DBMET01632 | DBMET01632 | |
| 0.039 | 0.599 | 0.312 | Cholesterol antagonist | 0.312 0.084 DBMET01632 | DBMET01632 | |
| 0.007 | 0.571 | 0.133 | Sphingosine 1-phosphate receptor 4 agonist | 0.133 0.012 DBMET01632 | DBMET01632 | |
| 0.012 | 0.579 | 0.215 | Phospholipase A2 inhibitor | 0.215 0.035 DBMET01632 | DBMET01632 | |
| 0.039 | 0.605 | 0.37 | Superoxide dismutase inhibitor | 0.37 0.032 DBMET01632 | DBMET01632 | |
| 0.086 | 0.654 | 0.26 | 5 Hydroxytryptamine 3E antagonist | 0.26 0.012 DBMET01632 | DBMET01632 | |
| 0.011 | 0.583 | 0.095 | Macrophage migration inhibitory factor inhibitor | 0.095 0.038 DBMET01632 | DBMET01632 | |
| 0.003 | 0.591 | 0.103 | Oleamide hydrolase inhibitor | 0.103 0.008 DBMET01632 | DBMET01632 | |
| 0.009 | 0.597 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.057 0.018 DBMET01632 | DBMET01632 | |
| 0.029 | 0.624 | 0.093 | Estrogen-related receptor beta agonist | 0.093 0.034 DBMET01632 | DBMET01632 | |
| 0.03 | 0.628 | 0.232 | Antithrombotic | 0.232 0.141 DBMET01632 | DBMET01632 | |
| 0.029 | 0.628 | 0.16 | Phospholipase C inhibitor | 0.16 0.087 DBMET01632 | DBMET01632 | |
| 0.061 | 0.662 | 0.215 | Tyrosine 3 hydroxylase inhibitor | 0.215 0.11 DBMET01632 | DBMET01632 | |
| 0.008 | 0.611 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.06 DBMET01632 | DBMET01632 | |
| 0.022 | 0.625 | 0.237 | Aldehyde oxidase inhibitor | 0.237 0.087 DBMET01632 | DBMET01632 | |
| 0.01 | 0.613 | 0.103 | Caspase 7 inhibitor | 0.103 0.026 DBMET01632 | DBMET01632 | |
| 0.006 | 0.624 | 0.044 | Melatonin receptor 1A agonist | 0.044 0.01 DBMET01632 | DBMET01632 | |
| 0.057 | 0.677 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.143 0.063 DBMET01632 | DBMET01632 | |
| 0.006 | 0.632 | 0.051 | Squalene epoxidase inhibitor | 0.051 0.032 DBMET01632 | DBMET01632 | |
| 0.001 | 0.629 | 0.013 | Immunosuppressant Cyclosporine-like | 0.013 0.006 DBMET01632 | DBMET01632 | |
| 0.027 | 0.661 | 0.144 | 3C-Like protease (SARS coronavirus) inhibitor | 0.144 0.011 DBMET01632 | DBMET01632 | |
| 0.006 | 0.643 | 0.027 | Glucosylceramidase stimulant | 0.027 0.022 DBMET01632 | DBMET01632 | |
| 0.017 | 0.654 | 0.132 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.132 0.033 DBMET01632 | DBMET01632 | |
| 0.017 | 0.66 | 0.371 | Calpain 2 inhibitor | 0.371 0.076 DBMET01632 | DBMET01632 | |
| 0.005 | 0.652 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | 0.054 0.03 DBMET01632 | DBMET01632 | |
| 0.01 | 0.658 | 0.109 | Uric acid excretion stimulant | 0.109 0.045 DBMET01632 | DBMET01632 | |
| 0.014 | 0.669 | 0.066 | Glutamate (mGluR6) antagonist | 0.066 0.048 DBMET01632 | DBMET01632 | |
| 0.003 | 0.668 | 0.026 | Prostaglandin F2 alpha agonist | 0.026 0.012 DBMET01632 | DBMET01632 | |
| 0.011 | 0.678 | 0.267 | Mannose-6-phosphate isomerase inhibitor | 0.267 0.009 DBMET01632 | DBMET01632 | |
| 0.024 | 0.693 | 0.202 | 3C-like protease (Human coronavirus) inhibitor | 0.202 0.051 DBMET01632 | DBMET01632 | |
| 0.004 | 0.686 | 0.063 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 DBMET01632 | DBMET01632 | |
| 0.004 | 0.69 | 0.242 | Catalase inhibitor | 0.242 0.009 DBMET01632 | DBMET01632 | |
| 0.019 | 0.706 | 0.134 | Photosensitizer | 0.134 0.043 DBMET01632 | DBMET01632 | |
| 0.007 | 0.694 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.031 DBMET01632 | DBMET01632 | |
| 0.004 | 0.693 | 0.089 | Monophenol monooxygenase inhibitor | 0.089 0.085 DBMET01632 | DBMET01632 | |
| 0.011 | 0.707 | 0.122 | Toll-Like receptor 2 antagonist | 0.122 0.075 DBMET01632 | DBMET01632 | |
| 0.013 | 0.709 | 0.1 | Proteasome inhibitor | 0.1 0.088 DBMET01632 | DBMET01632 | |
| 0.009 | 0.706 | 0.1 | Microtubule formation inhibitor | 0.1 0.092 DBMET01632 | DBMET01632 | |
| 0.015 | 0.714 | 0.093 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.045 DBMET01632 | DBMET01632 | |
| 0.009 | 0.71 | 0.193 | Lipoxygenase inhibitor | 0.193 0.148 DBMET01632 | DBMET01632 | |
| 0.015 | 0.733 | 0.079 | NADH dehydrogenase inhibitor | 0.079 0.077 DBMET01632 | DBMET01632 | |
| 0.008 | 0.73 | 0.125 | Creatine kinase inhibitor | 0.125 0.037 DBMET01632 | DBMET01632 | |
| 0.006 | 0.728 | 0.069 | Glutamate (mGluR7) antagonist | 0.069 0.045 DBMET01632 | DBMET01632 | |
| 0.012 | 0.736 | 0.141 | DOPA decarboxylase inhibitor | 0.141 0.026 DBMET01632 | DBMET01632 | |
| 0.02 | 0.75 | 0.147 | Histone acetyltransferase inhibitor | 0.147 0.144 DBMET01632 | DBMET01632 | |
| 0.008 | 0.741 | 0.165 | Insulin sensitizer | 0.165 0.114 DBMET01632 | DBMET01632 | |
| 0.003 | 0.74 | 0.072 | Xanthine dehydrogenase inhibitor | 0.072 0.03 DBMET01632 | DBMET01632 | |
| 0.001 | 0.745 | 0.032 | Glutamate (mGluR1a) agonist | 0.032 0.008 DBMET01632 | DBMET01632 | |
| 0.003 | 0.751 | 0.1 | Endothelin receptor antagonist | 0.1 0.005 DBMET01632 | DBMET01632 | |
| 0.029 | 0.792 | 0.316 | GABA C receptor rho-3 antagonist | 0.316 0.105 DBMET01632 | DBMET01632 | |
| 0.009 | 0.775 | 0.075 | Glutathione S-transferase inhibitor | 0.075 0.069 DBMET01632 | DBMET01632 | |
| 0.006 | 0.773 | 0.086 | Protease 3C (Human rhinovirus) inhibitor | 0.086 0.023 DBMET01632 | DBMET01632 | |
| 0.011 | 0.78 | 0.08 | Exportin-1 inhibitor | 0.08 0.025 DBMET01632 | DBMET01632 | |
| 0.008 | 0.779 | 0.301 | Alpha-N-acetylglucosaminidase inhibitor | 0.301 0.016 DBMET01632 | DBMET01632 | |
| 0.01 | 0.781 | 0.101 | Anabolic | 0.101 0.061 DBMET01632 | DBMET01632 | |
| 0.009 | 0.784 | 0.16 | Cathepsin H inhibitor | 0.16 0.04 DBMET01632 | DBMET01632 | |
| 0.009 | 0.786 | 0.138 | Thiol protease inhibitor | 0.138 0.083 DBMET01632 | DBMET01632 | |
| 0.011 | 0.793 | 0.262 | Triose-phosphate isomerase inhibitor | 0.262 0.006 DBMET01632 | DBMET01632 | |
| 0.009 | 0.793 | 0.262 | Succinate dehydrogenase inhibitor | 0.262 0.019 DBMET01632 | DBMET01632 | |
| 0.004 | 0.791 | 0.235 | Calpain inhibitor | 0.235 0.079 DBMET01632 | DBMET01632 | |
| 0.004 | 0.792 | 0.15 | Alcohol dehydrogenase inhibitor | 0.15 0.02 DBMET01632 | DBMET01632 | |
| 0.007 | 0.799 | 0.217 | UDP-glucose 4-epimerase inhibitor | 0.217 0.016 DBMET01632 | DBMET01632 | |
| 0.009 | 0.801 | 0.088 | Xanthine oxidase inhibitor | 0.088 0.074 DBMET01632 | DBMET01632 | |
| 0.011 | 0.807 | 0.161 | TRPA1 agonist | 0.161 0.024 DBMET01632 | DBMET01632 | |
| 0.006 | 0.806 | 0.085 | Glucose-6-phosphate isomerase inhibitor | 0.085 0.007 DBMET01632 | DBMET01632 | |
| 0.002 | 0.803 | 0.139 | Phosphofructokinase-1 inhibitor | 0.139 0.02 DBMET01632 | DBMET01632 | |
| 0.01 | 0.821 | 0.596 | Aldehyde dehydrogenase inhibitor | 0.596 0.004 DBMET01632 | DBMET01632 | |
| 0.004 | 0.818 | 0.064 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.064 0.026 DBMET01632 | DBMET01632 | |
| 0.003 | 0.82 | 0.219 | TRPA1 antagonist | 0.219 0.005 DBMET01632 | DBMET01632 | |
| 0.002 | 0.821 | 0.079 | Na+ K+ transporting ATPase inhibitor | 0.079 0.051 DBMET01632 | DBMET01632 | |
| 0.003 | 0.827 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.031 DBMET01632 | DBMET01632 | |
| 0.005 | 0.836 | 0.101 | GABA C receptor agonist | 0.101 0.065 DBMET01632 | DBMET01632 | |
| 0.001 | 0.838 | 0.047 | Geranyltranstransferase inhibitor | 0.047 0.027 DBMET01632 | DBMET01632 | |
| 0.004 | 0.851 | 0.117 | Ferrochelatase inhibitor | 0.117 0.056 DBMET01632 | DBMET01632 | |
| 0.004 | 0.858 | 0.033 | Retinoid X alpha receptor antagonist | 0.033 0.026 DBMET01632 | DBMET01632 | |
| 0.002 | 0.856 | 0.128 | Alcohol oxidase inhibitor | 0.128 0.013 DBMET01632 | DBMET01632 | |
| 0.004 | 0.863 | 0.037 | Retinoid X receptor antagonist | 0.037 0.029 DBMET01632 | DBMET01632 | |
| 0.013 | 0.887 | 0.157 | Adenylate kinase inhibitor | 0.157 0.024 DBMET01632 | DBMET01632 | |
| 0.002 | 0.877 | 0.113 | Glutamate decarboxylase inhibitor | 0.113 0.023 DBMET01632 | DBMET01632 | |
| 0.007 | 0.891 | 0.11 | Aminopeptidase B inhibitor | 0.11 0.058 DBMET01632 | DBMET01632 | |
| 0.002 | 0.887 | 0.069 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.069 0.026 DBMET01632 | DBMET01632 | |
| 0.001 | 0.893 | 0.05 | Ornithine carbamoyltransferase inhibitor | 0.05 0.04 DBMET01632 | DBMET01632 | |
| 0.001 | 0.907 | 0.065 | Argininosuccinate synthase inhibitor | 0.065 0.033 DBMET01632 | DBMET01632 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |